Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03496636 · ClinicalTrials.gov registry record · NA

Autologous Ovarian Tissue Transplantation

A NA study of Female Infertility, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT03496636: Recruiting NA study of Female Infertility, sponsored by University of Pittsburgh.

NCT03496636 is a NA study of Female Infertility that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03496636, a NA study of Female Infertility, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

Chemotherapy and radiation for cancer and other conditions can cause infertility. Several centers around the world are cryopreserving ovarian tissue from these patients though an experimental protocol, including the Fertility Preservation Program in Pittsburgh (protocol PRO08050491). The objective of this study is to study the efficacy and safety of autologous tissue transplantation in patients diagnosed with primary ovarian insufficiency after chemotherapy and/or radiation treatments.

Primary Outcome

Measure of reproductive hormone levels (FSH, AMH, LH E2 and others) to detect graft function

Conditions Studied

Interventions

  • PROCEDURE Ovarian tissue transplant

Study Locations (1)

Pennsylvania

  • Magee-Womens Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2021-03-01
Est. Completion 2027-09-01
Phase NA
University of Pittsburgh

1,238 total trials

What NCT03496636 shows while recruiting

NCT03496636 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Female Infertility appearing as the primary indexed condition, and to 1 intervention - of which Ovarian tissue transplant is the first listed.

NCT03496636 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03496636 about?

NCT03496636 is a clinical study titled "Autologous Ovarian Tissue Transplantation". Chemotherapy and radiation for cancer and other conditions can cause infertility. Several centers around the world are cryopreserving ovarian tissue from these patients though an experimental protocol, including the Fertility Preservation Program in Pittsburgh (protocol PRO08050491). The objective o...

What is the current status of trial NCT03496636?

This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2021-03-01. Estimated completion is 2027-09-01.

What conditions does trial NCT03496636 study?

This clinical trial studies the following conditions: Female Infertility.

What interventions are being tested in trial NCT03496636?

The interventions under investigation include: Ovarian tissue transplant (PROCEDURE).

Who is sponsoring clinical trial NCT03496636?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03496636 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT03496636's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03496636, the US trial registry maintained by the National Library of Medicine. NCT03496636 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.